BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed UNCY catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:302b28e85809c323be25@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20270325
DTEND;VALUE=DATE:20270326
SUMMARY:UNCY PDUFA (company-disclosed): PDUFA March 25\, 2027 - Unicycive T
 herapeutics\, Inc.
DESCRIPTION:PDUFA March 25\, 2027 - Unicycive Therapeutics\, Inc.\nConfiden
 ce: company-disclosed\nTicker UNCY (confidence 1.0)\nSource: https://www.s
 ec.gov/Archives/edgar/data/1766140/000121390026120261/ea031236501ex99-1.ht
 m\nScheduling/reference data from public records\; dates can move. Not inv
 estment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.sec.gov/Archives/edgar/data/1766140/000121390026120261/ea03
 1236501ex99-1.htm
CATEGORIES:pdufa,company-disclosed
END:VEVENT
BEGIN:VEVENT
UID:435c26f8a99be80586f6@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20260629
DTEND;VALUE=DATE:20260630
SUMMARY:UNCY CRL: oxylanthanum carbonate tablets
DESCRIPTION:CRL 2026-06-29: Unicycive Therapeutics Inc. NDA 218607 (oxylant
 hanum carbonate tablets)\nConfidence: confirmed\nTicker UNCY (confidence 0
 .9)\nSource: https://download.open.fda.gov/crl/CRL_NDA218607_20260629.pdf\
 nScheduling/reference data from public records\; dates can move. Not inves
 tment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://download.open.fda.gov/crl/CRL_NDA218607_20260629.pdf
CATEGORIES:crl,confirmed
END:VEVENT
END:VCALENDAR
